Company page

Vir Biotechnology, Inc.

Vir Biotechnology, Inc. is a public company traded under the ticker VIR in the American market. The company has a market capitalization of approximately $1.47 billion. Vir focuses on developing innovative therapies for infectious diseases and has a commitment to advancing its scientific research and product pipeline.